Clinical and Translational Allergy (Mar 2023)
COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents
Abstract
No abstracts available.Keywords
Clinical and Translational Allergy (Mar 2023)